N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  American Journal of Kidney Diseases

• Publication date

  2001-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/AJKD.2001.27695PMID 11576882
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms for the formation of glycoxidation products in end-stage renal disease.

  2000cited by this paper
• Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis.

  2000cited by this paper
• Increased serum levels of pentosidine, but not carboxymethyl lysine, in type 2 diabetes without obvious diabetic nephropathy.

  1999cited by this paper
• Advanced glycation end products: detection and reversal.

  1999cited by this paper
• Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia.

  1999cited by this paper
• Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.

  1999cited by this paper
• Measurement of Glomerular FiltrationRate by the 99m< /sup>Tc-DTPA Renogram Is Less Precise than Measured and Predicted Creatinine Clearance

  1999cited by this paper
• Comparison of advanced glycation endproducts on haemoglobin (Hb-AGE) and haemoglobin A1c for the assessment of diabetic control.

  1998cited by this paper
• Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.

  1998cited by this paper
• Renal catabolism of advanced glycation end products: the fate of pentosidine.

  1998cited by this paper
• The pathogenesis and consequences of AGE formation in uraemia and its treatment.

  1998cited by this paper
• Increased serum levels of advanced glycation end-products and diabetic complications.

  1998cited by this paper
• Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients.

  1998cited by this paper
• Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

  1997cited by this paper
• Determination of Advanced Glycation End Products in Serum by Fluorescence Spectroscopy and Competitive ELISA

  1997cited by this paper
• Formation of plasma advanced glycosylation end products (AGEs) has no influence on plasma viscosity

  1997cited by this paper
• Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells

  1996cited by this paper
• Advanced protein glycosylation in diabetes and aging.

  1995cited by this paper
• Immunological determination of advanced glycosylation end-products in human blood and urine.

  1995cited by this paper
• Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

  1994cited by this paper
• Relationships between glycation and oxidation related fluorescences in rat collagen during aging. An in vivo and in vitro study.

  1994cited by this paper
• Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure.

  1994cited by this paper
• Effect of Diabetes and Aging on Carboxymethyllysine Levels in Human Urine

  1991cited by this paper
• Accelerated age-related browning of human collagen in diabetes mellitus.

  1984cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper

• Menaquinone-7 Supplementation Increases Multiple Advanced Glycation End-Products and Oxidation Markers in Zucker Diabetic Fatty Rats

  2025cites this paper
• Spinach Extract Reduces Kidney Damage in Diabetic Rats by Impairing the AGEs/RAGE Axis

  2025cites this paper
• Serum Levels of Nε-(Carboxymethyl)-Lysine in Chronic Kidney Disease and Type 2 Diabetes Mellitus

  2025cites this paper
• An immunosensor for the detection of N-(carboxymethyl)lysine - a diabetic biomarker

  2025cites this paper
• A One-Month Advanced Glycation End Products—Restricted Diet Improves CML, RAGE, Metabolic and Inflammatory Profile in Patients with End-Stage Renal Disease Undergoing Haemodialysis

  2024cites this paper
• Methylglyoxal-induces multiple stable changes in human serum albumin before forming nephrotoxic advanced glycation end-products: Injury demonstration in human embryonic kidney cells.

  2022cites this paper
• Metabolic and Metabo-Clinical Signatures of Type 2 Diabetes, Obesity, Retinopathy, and Dyslipidemia

  2022cites this paper
• Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?

  2022cites this paper
• Association of serum advanced glycation (AGEs) end products, apolipoprotein-B and zinc in severity of T2DM retinopathy.

  2021cites this paper
• Differences in AGEs-N-Carboxymethyllysine and Kidney Injury Molecule-1 in non-diabetic subjects, diabetic with and without diabetic nephropathy

  2021cites this paper
• Metabolic and Metabo-Clinical Signatures of T2D, Obesity, Retinopathy and Dyslipidemia.

  2021cites this paper
• In Vitro and In Vivo Antiglycation Effects of Connarus ruber Extract

  2021cites this paper
• DIAGNOSTIC SENSITIVITY OF BIOMARKERS IN ASSESSING THE OCCURRENCE AND PROGRESSION OF DIABETIC NEPHROPATHY

  2021cites this paper
• Development and Application of Mass Spectroscopy Assays for Nε-(1-Carboxymethyl)-L-Lysine and Pentosidine in Renal Failure and Diabetes.

  2020cites this paper
• Controlled Formation of Carboxymethyllysine in Bone Matrix through Designed Glycation Reaction

  2020cites this paper
• UV Fluorescence-Based Determination of Urinary Advanced Glycation End Products in Patients with Chronic Kidney Disease

  2020cites this paper
• Dietary Advanced Glycation Endproducts and the Gastrointestinal Tract

  2020cites this paper
• Glycated proteins in nutrition: Friend or foe?

  2019cites this paper
• Circulating levels of Hsp27 in microvascular complications of diabetes: Prospects as a biomarker of diabetic nephropathy.

  2018cites this paper
• Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial

  2018cites this paper
• Correlation Between Advanced Glycation End‐Products, Lower Urinary Tract Symptoms and Bladder Dysfunctions in Patients with type 2 Diabetes Mellitus

  2017cites this paper
• University of Groningen The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress , Inflammation , Disease Severity , and Mortality during ICU Admission in Critically Ill Patients

  2017cites this paper
• Serum Fluorescent Advanced Glycation End (F-AGE) products in gestational diabetes patients

  2017cites this paper
• Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect

  2016cites this paper
• Glycemic Index and Diabetes Mellitus: Evidence on Prevention and Management and Implications on Insulin Resistance

  2016cites this paper
• Glucose degradation products in patients on hemodialysis : interventional studies

  2016cites this paper
• The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study

  2016cites this paper
• Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies.

  2016cites this paper
• Inhibition of autophagy increased AGE/ROS-mediated apoptosis in mesangial cells

  2016cites this paper
• Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A Review

  2016cites this paper
• Resveratrol Causes Gender-dependent and Bardoxolone Methyl-like Effects in Patients with IgA Nephropathy: Pilot Study

  2016cites this paper
• Resveratrol Causes Gender-dependent and Bardoxolone Methyl-likeEffects in Patients with IgA Nephropathy: Pilot Study

  2016cites this paper
• Increased accumulation of protein-bound N(ε)-(carboxymethyl)lysine in tissues of healthy rats after chronic oral N(ε)-(carboxymethyl)lysine.

  2015cites this paper
• Fluorophores advanced glycation end products (AGEs)-to-NADH ratio is predictor for diabetic chronic kidney and cardiovascular disease.

  2015cites this paper
• Synthesis and Characterization of New 1,2,4‐Triazolo[1,5‐a]pyridines That Extend the Life Span of Caenorhabiditis elegans via Their Anti‐Inflammatory/Antioxidant Effects

  2015cites this paper
• Impact of glycemic control on advanced glycation and inflammation in overweight and obese patients with type 2 diabetes mellitus.

  2014cites this paper
• Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients.

  2013cites this paper
• Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction

  2013cites this paper
• Advanced Glycation End Products Acutely Impair Ca2+ Signaling in Bovine Aortic Endothelial Cells

  2013cites this paper
• Advanced glycation end products and diabetic retinopathy.

  2013cites this paper
• Advanced glycation endproducts in food and their effects on health.

  2013cites this paper
• Life span extension of Caenorhabditis elegans by novel pyridoperimidine derivative

  2012cites this paper
• Advanced glycation end products and diabetic retinopathy

  2012cites this paper
• Genistein Attenuates Advanced Glycation End Product-Induced Expression of Fibronectin and Connective Tissue Growth Factor

  2012cites this paper
• Cardiovascular risk and its determinants in high risk patients

  2012cites this paper
• Increased DNA-glycation in type 2 diabetic patients: the effect of thiamine and pyridoxine therapy.

  2012cites this paper
• The glycation pathway in type 2 diabetes and cardiovascular disease

  2012cites this paper
• Immune and metabolic changes leading to diabetes

  2012cites this paper
• Novel 1,2,4-triazolo[1,5-a]pyridines and their fused ring systems attenuate oxidative stress and prolong lifespan of Caenorhabiditis elegans.

  2012cites this paper
• Diabetes-related adduct formation and retinopathy

  2011cites this paper
• Advanced Glycation Urinary Protein-Bound Biomarkers and Severity of Diabetic Nephropathy in Man

  2011cites this paper
• Ferulsinaic acid attenuation of advanced glycation end products extends the lifespan of Caenorhabditis elegans

  2011cites this paper
• AGE formation blockade with aminoguanidine does not ameliorate chronic allograft nephropathy.

  2011cites this paper
• Advanced Glycation Urinary Protein-Bound Biomarkers and Severity of Diabetic Nephropathy in Man

  2011cites this paper
• Dietary hyperglycemia, glycemic index and metabolic retinal diseases.

  2011cites this paper
• Consequences of Advanced Glycation End Products Accumulation in Chronic Kidney Disease and Clinical Usefulness of Their Assessment Using a Non-invasive Technique - Skin Autofluorescence.

  2011cites this paper
• Naturally occurring inhibitors against the formation of advanced glycation end-products.

  2011cites this paper
• Protective actions of microalgae against endogenous and exogenous advanced glycation endproducts (AGEs) in human retinal pigment epithelial cells.

  2011cites this paper
• Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy.

  2010cites this paper
• Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy

  2010cites this paper
• Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy.

  2010cites this paper
• MEASUREMENT OF ALBUMINURIA WITH SIZE-EXCLUSION CHROMATOGRAPHY CHARACTERIZATION AND NEW PERSPECTIVES

  2010cites this paper
• AGEs and diabetic retinopathy.

  2010cites this paper
• Advanced glycation end‐products and the kidney

  2010cites this paper
• Involvement of Toxic AGEs (TAGE) in the Pathogenesis of Diabetic Vascular Complications and Alzheimer's Disease

  2009cites this paper
• Therapeutic Potential of Green Tea Extract and Low Doses of γ-Irradiation on Diabetic Nephropathy of Rats

  2009cites this paper
• G allele at RAGE SNP82 is associated with proinflammatory markers in obese subjects.

  2009cites this paper
• Glycoxidized LDL increases lectin-like oxidized low density lipoprotein receptor-1 in diabetes mellitus.

  2009cites this paper
• Measurement of the modification and interference rate of urinary albumin detected by size-exclusion HPLC

  2009cites this paper
• Biologic Variability in Plasma Glucose, Hemoglobin A1c, and Advanced Glycation End Products Associated with Diabetes Complications

  2009cites this paper
• Correlation of low molecular weight advanced glycation end products and nitric oxide metabolites with chronic complications in type 1 diabetic patients

  2008cites this paper
• Glyoxalase‐1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans

  2008cites this paper
• Cardiovascular disease in patients with diabetic nephropathy.

  2008cites this paper
• Nɛ‐(Carboxymethyl)lysine during the Early Development of Hypertension

  2008cites this paper
• Rosiglitazone Reduces Angiotensin II and Advanced Glycation End Product-dependent Sustained Nuclear Factor-κB Activation in Cultured Human Proximal Tubular Epithelial Cells

  2008cites this paper
• Advanced glycation index and its association with severity of diabetic retinopathy in type 2 diabetic subjects.

  2008cites this paper
• Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.

  2008cites this paper
• Skin autofluorescence in diabetes mellitus

  2008cites this paper
• The Role of Advanced Glycation in Diabetic Retinopathy

  2008cites this paper
• Development and post-pilot modification of a questionnaire for assessing dietary AGE intake in Australian children with and without type 1 diabetes mellitus

  2008influential citation
• Unchanged serum levels of advanced glycation endproducts in patients with liver disease

  2007cites this paper
• Advanced glycation endproducts: a biomarker for age as an outcome predictor after cardiac surgery?

  2007cites this paper
• Hemodialysis and Protein Oxidation Products

  2007cites this paper
• Evaluation of a gas chromatography/mass spectrometry method for the quantification of carboxymethyllysine in food samples.

  2007cites this paper
• Serum carboxymethyllysine predicts mortality in hemodialysis patients.

  2006cites this paper
• The Advanced Glycation End Product Nε-Carboxymethyllysine Is Not a Predictor of Cardiovascular Events and Renal Outcomes in Patients With Type 2 Diabetic Kidney Disease and Hypertension

  2006cites this paper
• TAGE (toxic AGEs) theory in diabetic complications.

  2006cites this paper
• The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.

  2006cites this paper
• N2-carboxyethyl-2'-deoxyguanosine, a DNA glycation marker, in kidneys and aortas of diabetic and uremic patients.

  2006cites this paper
• Glycation Products as Markers and Predictors of the Progression of Diabetic Complications

  2005influential citation
• Clinical implications of Nε‐(carboxymethyl)lysine, advanced glycation end product, in children and adolescents with type 1 diabetes

  2005cites this paper
• Advanced glycation end product is implicated in amyloid‐related kidney complications

  2005cites this paper
• Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.

  2005cites this paper
• Advanced glycation and retinal pathology during diabetes.

  2005cites this paper
• The Maillard Reaction in Eye Diseases

  2005cites this paper
• Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition

  2005cites this paper
• Oxidative stress and non-enzymatic glycation in IgA nephropathy.

  2005cites this paper
• AGE-RAGE and AGE Cross-link Interaction: Important Players in the Pathogenesis of Diabetic Kidney Disease

  2005cites this paper
• Cardiovascular risk in patients with end-stage renal disease: a potential role for advanced glycation end products.

  2005cites this paper
• A novel advanced glycation index and its association with diabetes and microangiopathy.

  2005cites this paper